Lifecore Biomedical, Inc.

General ticker "LFCR" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $210.0M (TTM average)

Lifecore Biomedical, Inc. follows the US Stock Market performance with the rate: 53.3%.

Estimated limits based on current volatility of 1.8%: low 7.53$, high 7.80$

Factors to consider:

  • Total employees count: 459 as of 2023
  • Current price 10.7% above estimated high
  • Earnings for 15 months up through Q1 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-05-26 to 2026-05-26

  • 2024-05-26 to 2025-05-26 estimated range: [3.36$, 7.57$]
  • 2025-05-26 to 2026-05-26 estimated range: [3.14$, 7.05$]

Financial Metrics affecting the LFCR estimates:

  • Positive: with PPE of -12.2 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of 0.14 <= 0.33
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.54
  • Positive: -14.38 < Investing cash flow per share per price, % of -10.25
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of -0.68 <= -0.15

Similar symbols

Short-term LFCR quotes

Long-term LFCR plot with estimates

Financial data

YTD 2022-05-29 2023-05-28 2024-05-26
Operating Revenue $111.27MM $103.27MM $128.26MM
Operating Expenses $123.06MM $125.06MM $137.10MM
Operating Income $-11.79MM $-21.80MM $-8.84MM
Non-Operating Income $-8.90MM $-42.13MM $18.36MM
Interest Expense $15.55MM $17.65MM $18.09MM
R&D Expense $7.84MM $8.74MM $8.57MM
Income(Loss) $-20.69MM $-63.93MM $9.51MM
Taxes $-5.21MM $0.31MM $0.18MM
Profit(Loss)* $-116.72MM $-99.56MM $12.01MM
Stockholders Equity $87.82MM $-4.23MM $11.31MM
Inventory $36.00MM $40.84MM $39.98MM
Assets $274.70MM $253.54MM $253.96MM
Operating Cash Flow $-22.59MM $-17.44MM $0.26MM
Capital expenditure $29.94MM $21.48MM $18.39MM
Investing Cash Flow $79.96MM $-4.81MM $-18.39MM
Financing Cash Flow $-57.02MM $39.70MM $7.51MM
Earnings Per Share** $-3.96 $-3.32 $0.39

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.